3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Neoplasm Metastasis
25
Leukemia, Myeloid, Acute
25
Breast Neoplasms
18
Prostatic Neoplasms
16
Myelodysplastic Syndromes
15
Lymphoma, Large B-Cell, Diffuse
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Multiple Myeloma
14
Lung Neoplasms
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Colorectal Neoplasms
12
Carcinoma, Non-Small-Cell Lung
12
Triple Negative Breast Neoplasms
11
Pancreatic Neoplasms
11
Burkitt Lymphoma
11
Neoplasms
9
Lymphoma, Mantle-Cell
9
Leukemia, Myelomonocytic, Chronic
9
Ovarian Neoplasms
8
Melanoma
8
Stomach Neoplasms
7
Lymphoma, T-Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Lymphoma, B-Cell
6
Carcinoma, Renal Cell
6
Myeloproliferative Disorders
5
Mouth Neoplasms
5
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Fallopian Tube Neoplasms
5
Interventions
relatlimab
1
pembrolizumab
1
enfortumab vedotin
1
darolutamide
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Nivolumab
1
Mitomycin
1
Human Papillomavirus DNA Tests
1
Gemcitabine
1
Fluorouracil
1
Colposcopy
1
Cisplatin
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Urogenital Diseases
×
Biopsy
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled